Article

Transvaginal mesh controversy: Careful patient selection is key

Howard Goldman, MD, discusses the possible effects of FDA reclassification of transvaginal mesh used for prolapse as well as the importance of adequate surgical training and patient selection.

Related Videos
Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
1 expert is featured in this series.
1 expert is featured in this series.
Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
2 experts are featured in this series.
2 experts are featured in this series.
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
© 2025 MJH Life Sciences

All rights reserved.